Home » Authors » James Etheridge

Articles by James Etheridge

Ricerca Begins Cancer Portfolio, Licenses Genset’s RAP-3 Gene

March 20, 2002

By James Etheridge

Galapagos Genomics Closes $18.7M Initial Funding Round

March 13, 2002

By James Etheridge

Galapagos Genomics Closes $18.7M Initial Funding Round

March 13, 2002

By James Etheridge

Genset Sells Division, Secures Equity Line Of Up To EUR30M

March 6, 2002

By James Etheridge

Innate Pharma Seeking $13M To Develop Cancer Therapies

March 6, 2002

By James Etheridge

Innate Pharma Seeking $13M To Develop Cancer Therapies

March 6, 2002

By James Etheridge

Genset Sells Division, Secures Equity Line Of Up To EUR30M

March 6, 2002

By James Etheridge

French Challenge Another Myriad Patent On Breast Cancer Gene

Feb. 27, 2002

By James Etheridge

French Challenge Another Myriad Patent On Breast Cancer Gene

Feb. 27, 2002

By James Etheridge

Sanofi-Synthélabo Selects Melanoma Vaccine From IDM

Feb. 20, 2002

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.